---
figid: PMC12109847__cimb-47-00347-g003
figtitle: MiR-21 modulates the MAPK/MEK/ERK signaling pathway directly by downregulating
  the SPRY and DUSPs that normally suppress ERK activation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12109847
filename: cimb-47-00347-g003.jpg
figlink: /pmc/articles/PMC12109847/figure/F3/
number: F3
caption: MiR-21 modulates the MAPK/MEK/ERK signaling pathway directly by downregulating
  the SPRY and DUSPs that normally suppress ERK activation. MiR-21 facilitates sustained
  MEK ERK phosphorylation by suppressing certain inhibitors, thereby enhancing cell
  proliferation and survival. Dysregulation fuels unchecked growth in tumor cells,
  fostering resistance in apoptosis that occurs sporadically amidst rapid proliferation.
  The figure illustrates the role of miR-21 in modulating the MAPK/MEK/ERK pathway,
  emphasizing its deep oncogenic influence in cancer development processes [73,74,75,76].
  Created with BioRender.com; https://BioRender.com/e16k991 (accessed on 8 February
  2025)
papertitle: Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications
reftext: Dimitrios Stefanoudakis, et al. Curr Issues Mol Biol. 2025 May;47(5).
year: '2025'
doi: 10.3390/cimb47050347
journal_title: Current Issues in Molecular Biology
journal_nlm_ta: Curr Issues Mol Biol
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: cancer detection | cancer biomarkers | pancreatic cancer | microRNA | GATA6
  | L1CAM | MUC1
automl_pathway: 0.9202715
figid_alias: PMC12109847__F3
figtype: Figure
redirect_from: /figures/PMC12109847__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12109847__cimb-47-00347-g003.html
  '@type': Dataset
  description: MiR-21 modulates the MAPK/MEK/ERK signaling pathway directly by downregulating
    the SPRY and DUSPs that normally suppress ERK activation. MiR-21 facilitates sustained
    MEK ERK phosphorylation by suppressing certain inhibitors, thereby enhancing cell
    proliferation and survival. Dysregulation fuels unchecked growth in tumor cells,
    fostering resistance in apoptosis that occurs sporadically amidst rapid proliferation.
    The figure illustrates the role of miR-21 in modulating the MAPK/MEK/ERK pathway,
    emphasizing its deep oncogenic influence in cancer development processes [73,74,75,76].
    Created with BioRender.com; https://BioRender.com/e16k991 (accessed on 8 February
    2025)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - KRAS
  - HRAS
  - NRAS
  - MAP3K8
  - MIR21
  - BRAF
  - ARAF
  - RAF1
  - RNASE3
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - SPRY1
  - SPRY2
  - SPRY3
  - SPRY4
  - ELK1
  - KCNH4
  - KCNH8
  - ATF2
  - GDNF
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - MYEF2
  - STAT1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - CEBPA
  - Ras
  - AP1
---
